HBK Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-6,435
Closed -$291K – 100
2019
Q4
$291K Buy
+6,435
New +$269K ﹤0.01% 611
2019
Q2
– Sell
-47,125
Closed -$1.81M – 662
2019
Q1
$1.81M Buy
+47,125
New +$1.8M 0.02% 542
2018
Q4
– Sell
-24,507
Closed -$944K – 1204
2018
Q3
$944K Sell
24,507
-279,650
-92% -$9.77M 0.01% 736
2018
Q2
$9.95M Sell
304,157
-330,843
-52% -$9.98M 0.07% 168
2018
Q1
$17.3M Buy
635,000
+533,500
+526% +$14.5M 0.12% 95
2017
Q4
$2.52M Buy
+101,500
New +$2.8M 0.02% 400
2016
Q4
– Sell
-82,983
Closed -$1.98M – 736
2016
Q3
$1.98M Sell
82,983
-21,736
-21% -$519K 0.02% 371
2016
Q2
$2.45M Buy
+104,719
New +$2.27M 0.02% 370
2014
Q4
– Sell
-316,500
Closed -$3.74M – 987
2014
Q3
$3.74M Buy
316,500
+104,300
+49% +$1.31M 0.06% 251
2014
Q2
$2.71M Buy
+212,200
New +$2.76M 0.06% 284
2014
Q1
– Sell
-390,300
Closed -$4.69M – 907
2013
Q4
$4.69M Buy
390,300
+155,300
+66% +$1.83M 0.09% 151
2013
Q3
$2.76M Buy
235,000
+30,804
+15% +$333K 0.04% 228
2013
Q2
$1.89M Buy
+204,196
New +$1.73M 0.03% 274

Other funds holding BSX

HBK Investments's BSX Position: Q1 2020 in Review

HBK Investments sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 6,435 shares — an estimated $291K sold.

HBK Investments first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $17.3M in Q1 2018. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • HBK Investments reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • HBK Investments sold 6,435 Boston Scientific shares in Q1 2020, an estimated $291K.
  • HBK Investments first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
  • HBK Investments's Boston Scientific position peaked at $17.3M in Q1 2018.
  • 801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.